Mohnish Pabrai: The Cloner Who Turned $1M Into $1B

In 1994, Mohnish Pabrai sold his IT services company, kept roughly $1 million, and decided to invest the proceeds the way Warren Buffett did — openly, without apology, in concentrated bets on a handful of misunderstood businesses. By 2018 that roughly $1 million had compounded to almost $1 billion. He did it with one rule most investors refuse: clone Berkshire Hathaway (BRKB) and other super-investors instead of inventing original ideas.

What Is the "Dhandho" Origin Story?

Pabrai was born in India and immigrated to the US in 1982 with no investing background. He built a successful IT services company called TransTech and sold it in the late 1990s. With the proceeds, instead of starting another operating business, he chose to compound capital — and the only model he respected enough to copy was Warren Buffett's.

He named his investing approach "Dhandho," from the Gujarati word for "endeavor that creates wealth." The core idea: take bets where the downside is bounded and the upside is uncapped — and only take such bets when the odds are obviously in your favor. It is closer to a coin-flip framework than to traditional security analysis.

The Pabrai Funds launched in 1999. By the time he wrote The Dhandho Investor in 2007, the fund had compounded at roughly 28% per year — a number that put him in conversation with Buffett, Munger, and the original Graham-Dodd disciples.

What Is His Investment Philosophy?

The philosophy is summed up by one phrase Pabrai repeats: "Heads I win, tails I don't lose much." Every position should have a sharply asymmetric payoff. The cost of being wrong should be a small fraction of the gain from being right.

That sounds simple. The hard part is the discipline to wait — sometimes for years — until such an asymmetry shows up. Pabrai is fine doing nothing for 12-18 months. Most professional investors are not, because their compensation is tied to activity. Patience is the actual moat in his playbook, not the framework itself.

He also borrows directly from Buffett's checklist: invest only in businesses you understand, with durable competitive advantages, run by managers you respect, and only at prices that offer a meaningful margin of safety. The difference is that Pabrai is willing to ignore quality if the price is absurdly low — closer to Graham than to Buffett-Munger.

What Are His 5 Key Principles?

The Dhandho framework distills into five rules:

1. Buy existing businesses, not start-ups. Public-equity investors have the advantage that someone else has already proven the model works.
2. Buy simple businesses in industries with ultra-slow rates of change. Coca-Cola (KO) was Buffett's textbook example; cement and steel are Pabrai's modern variants.
3. Buy distressed businesses in distressed industries. Most of Pabrai's biggest wins came when one segment was being left for dead — auto parts in 2009, coal in 2020-2021.
4. Buy with a wide margin of safety. The classical Graham concept — pay 50 cents for a dollar of value, not 80 cents.
5. Bet rarely, but bet big. Position sizing is the multiplier; roughly 10% bets are the floor for high-conviction names.

For more on how this fits into broader frameworks, see the investment strategies primer.

What Are His Most Famous Quotes?

A few that show up in his interviews and in The Dhandho Investor:

• "Few bets, big bets, infrequent bets."
• "All I want to know is where I'm going to die, so I'll never go there." (Quoting Charlie Munger but living the rule.)
• "Clone everything that works. There is no shame in it."
• "The first rule of compounding: never interrupt it unnecessarily."
• "Heads I win, tails I don't lose much."

The clone rule is the most controversial. Pabrai openly mines 13F filings of super-investors he trusts — Buffett, Munger, Li Lu, Guy Spier — and treats their concentrated positions as an idea screen. He does original work before buying. But the entry point is somebody else's homework.

What Are His Notable Trades and Holdings?

Pabrai's career has been built on a handful of outsized winners that paid for many small mistakes:

In recent years, Pabrai has rotated heavily into commodity-cyclicals — coal, energy services, and integrated oil. He has publicly explained that the cycle setup (under-investment plus supply-side discipline) reminded him of the 2009 banking distress. In any given quarter, Pabrai is willing to hold his entire roughly $400M+ portfolio in five positions — a level of concentration that would get a typical mutual fund manager fired.

Investors who want to follow his style at scale typically pair his cyclical bets — exposure to names like XOM and CVX when the cycle is right — with quality compounders like JPM and BAC, holding them across the cycle rather than trading them.

How Has He Performed?

The clean numbers, where they have been disclosed: Pabrai Funds compounded at roughly 28% annually from inception (1999) through 2007, dramatically outperforming the S&P 500 over that window. The 2008-2009 drawdown was severe — concentrated value managers got hit hard — but the recovery into 2010-2014 restored most of the gap.

The honest part of his performance history: there have been multi-year stretches (2015-2018, parts of 2021-2023) where his style lagged the broad market. Concentration is a double-edged sword. When he is right, the compounding is breathtaking. When he is wrong or early — energy in the mid-2010s, for example — he can underperform for 36 months at a time.

He has never claimed to outperform every year. He has only claimed to outperform across cycles. The data, on balance, supports him.

What Are the Lessons for Individual Investors?

Three things worth borrowing from Pabrai's playbook, even if you do not run a concentrated five-stock portfolio yourself:

• Use 13Fs as a screen, not a signal. Look at what super-investors are buying. Then do your own work on the top three. You will find ideas you would never have surfaced from a basic screener.
• Wait for the asymmetry. Most portfolio underperformance comes from forcing trades when nothing is obviously cheap. The Pabrai habit of doing nothing for 12-18 months is, statistically, the right default.
• Pair concentration with simple businesses. Concentration in a complex business is just leverage on your own ignorance. Concentration in a business with a five-page thesis is leverage on the thesis.

For more on the broader school of concentrated value investing, see the super-investors framework.

What Is the Honest Counter-Argument?

The counter-argument is that Pabrai's outperformance history is partly survivorship bias — the value managers who blew up in 2008 do not write books. Concentration cuts both ways: a five-stock portfolio that owns the wrong five stocks for 36 months is one of the worst experiences in investing.

The other honest critique is that the "clone" framework assumes super-investors are themselves still right. Buffett's edge has narrowed as Berkshire's asset base grew; some of the original Graham-Dodd disciples lagged for a decade before retiring. Pabrai's screen has to keep evolving with the dominant style cycle.

None of this voids the underlying lessons. It just means borrowing from Pabrai requires the same discipline he demands of himself — patience, asymmetric setups, and the willingness to look wrong for years.

Ready to analyze these stocks yourself? Search any ticker on MainRatios to see valuations from 6 legendary investors - free.